Remdesivir vs. Ivermectin

Remdesivir vs. Ivermectin

Molnupiravir vs. Ivermectin(continued from How Profitable Are Covid Vaccines?)

"How does Ivermectin compare vs. Remdesivir?"

The Remdesivir vs. Ivermectin comparison yields a stark contrast.


When Satoshi Omura and William Campbell were awarded the 2015 Nobel Prize for Physiology or Medicine for having discovered Ivermectin in 1970, it was the first time in six decades that the prize had been awarded for the discovery of a drug against infectious diseases. In other words, the Nobel Committee for Physiology or Medicine recognized Ivermectin as the most significant new drug discovery against infectious diseases in sixty years. The World Health Organization (WHO) also recognizes Ivermectin, as one of the "Essential Medicines" for the world (source). Ivermectin is safe, cheap, and has been proven to be effective against COVID-19 (see Ivermectin).


Remdesivir was originally developed by Gilead Sciences for Ebola and MERS but was never used because it had no efficacy, destroyed the liver and/or the kidneys in 48% of those who received it during the clinical trials - "25% of patients receiving [Remdesivir] have severe side effects, including multiple-organ dysfunction syndrome, septic shock, acute kidney injury and low blood pressure. Another 23% demonstrated evidence of liver damage on lab tests" (source) - and killed over 50% of those who received it:

When the COVID-19 pandemic began, Gilead dusted off Remdesivir and handed it off to Anthony Fauci, who manipulated its clinical trial results to ram it through the FDA (details) and promoted it as "the standard of care" for COVID-19 (watch). Remdesivir has now been proven to be both ineffective against COVID-19 and toxic, and the WHO now warns "against the use of Remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that Remdesivir improves survival and other outcomes in these patient" (source).

Here is a side-by-side comparison of Remdesivir vs. Ivermectin:

  Ivermectin Remdesivir
COVID-19 mortality reduction 89% 0%
COVID-19 morbidity reduction 86% 0%
Severe side effects rate 0.0% 25%
Liver damage rate 0.0% 23%
Patented by Merck Gilead
Patented in 1976 2020
Used by humans since 1987 2020
Safety record of 34 years < 1 year
Patent expiry 1997 2040
Today made by Many firms Gilead
Cost of ingredients < $1 < $10
Price per treatment < $10 > $2,300
Why do FDA, NIH and CDC recommend Remdesivir but denigrate Ivermectin?

To gain approval, new vaccines must be tested in at least 3,000 human subjects and then wait for at least two years to see if any major medium-term side effects, including birth defects or disabilities in babies born to women who took the vaccine before or during their pregnancies, surface. This waiting period can be exceptionally waived and an Emergency Use Authorization (EUA) granted to a new vaccine if there is an epidemic and no drug exists that can deal with it. For the COVID-19 vaccine makers to be granted their EUAs, a drug like Remdesivir that is ineffective against COVID-19 may exists, but a drug like Ivermectin that is effective against COVID-19 must not exist.

The vaccine makers and their surrogates in the government and the media who colluded to block the use of Ivermectin and the news of its efficacy against COVID-19 have caused millions of people to die needlessly for the sake of corporate profits, and should be tried for crimes against humanity (see Big Pharma Corruption and Fire Anthony Fauci).

>> Continued